Cases & Deals

Share

Daphni invests in Ternary Therapeutics

June 2025

Client(s) Daphni

Jones Day advised venture capital fund Daphni as lead investor on its investment into Ternary Therapeutics, an early-stage UK-based biotech innovator. Ternary Therapeutics is bridging AI, computational chemistry, and molecular dynamics to design next-generation molecular glue therapeutics.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.